Details for 2017776462
Up to date per 04.04.2026
Actions
Details for 2017776462
Granted/Registered
European Patent
06.02.2019 A
23.11.2022 B1
28.03.2016
US
201662314116 P
C12N 15/861 20060101AFI20190910BHEP
Owner
Ultragenyx Pharmaceutical Inc.60 Leveroni Court Novato, CA 94949US
Representative
Representative
Dipl.-Ing. Dr. techn. Gerda RedlDonau-City-Straße 111220 WIENAT
Inventor
MORRISON, Christopher, J.73 School St. Arlington, MA 02476US
MARATT, James, D.44 Lewis Road Belmont, MA 02478US
Information about Fees